If you have been diagnosed with metastatic breast cancer, resources like support groups, counseling, financial assistance, and online communities can help.
The US regulator has cleared TROP2-directed ADC datopotamab deruxtecan (Dato-DXd) under the Datroway trade name as a ...
DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback